Literature DB >> 17159138

CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiation.

James M Carr1, Marlene J Carrasco, James E D Thaventhiran, Paul J Bambrough, Matthew Kraman, Alexander D Edwards, Aymen Al-Shamkhani, Douglas T Fearon.   

Abstract

The clonal expansion of antigen-specific CD8+ T cells in response to microbial infections is essential for adaptive immunity. Although IL-2 has been considered to be primarily responsible for this process, quantitatively normal expansion occurs in the absence of IL-2 receptor signaling. Here, we show that ligating CD27 on CD8+ T cells that have been stimulated through the T cell receptor causes their expansion in the absence of IL-2 by mediating two distinct cellular processes: enhancing cell cycling and promoting cell survival by maintaining the expression of IL-7 receptor alpha. This pathway for clonal expansion of the CD8+ T cell is not associated with the development of a capacity either for production of IFN-gamma or for cytotoxic T lymphocyte function and, therefore, is uncoupled from differentiation. Furthermore, ligating CD27 increases the threshold concentration at which IL-2 induces IFN-gamma-producing capability by the CD8+ T cell, suggesting that CD27 signaling may suppress effector differentiation. Finally, CD8+ T cells that have been stimulated by the TCR/CD27 pathway maintain their capacity for subsequent expansion and effector differentiation in response to a viral challenge in vivo. Thus, the TCR/CD27 pathway enables the CD8+ T cell to replicate by a process of self-renewal, which may contribute to the continuous generation of new effector CD8+ T cells in persistent viral infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17159138      PMCID: PMC1697827          DOI: 10.1073/pnas.0609706104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules.

Authors:  Eckart Schott; Nicolas Bertho; Qing Ge; Madelon M Maurice; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

2.  BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes.

Authors:  Peter M Manders; Patricia J Hunter; Aino I Telaranta; James M Carr; Jennifer L Marshall; Marlene Carrasco; Yusuke Murakami; Michael J Palmowski; Vincenzo Cerundolo; Susan M Kaech; Rafi Ahmed; Douglas T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-15       Impact factor: 11.205

3.  Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation.

Authors:  Robert Thimme; Victor Appay; Marie Koschella; Elisabeth Panther; Evelyn Roth; Andrew D Hislop; Alan B Rickinson; Sarah L Rowland-Jones; Hubert E Blum; Hanspeter Pircher
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 4.  The rationale for the IL-2-independent generation of the self-renewing central memory CD8+ T cells.

Authors:  Douglas T Fearon; James M Carr; Aino Telaranta; Marlene J Carrasco; James E D Thaventhiran
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

5.  Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.

Authors:  Luca Gattinoni; Christopher A Klebanoff; Douglas C Palmer; Claudia Wrzesinski; Keith Kerstann; Zhiya Yu; Steven E Finkelstein; Marc R Theoret; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

6.  Cutting edge: CD95 maintains effector T cell homeostasis in chronic immune activation.

Authors:  Ramon Arens; Paul A Baars; Margot Jak; Kiki Tesselaar; Martin van der Valk; Marinus H J van Oers; René A W van Lier
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

7.  Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL.

Authors:  Matthias Matter; Sabine Mumprecht; Daniel D Pinschewer; Viktor Pavelic; Hideo Yagita; Stefan Krautwald; Jannie Borst; Adrian F Ochsenbein
Journal:  Eur J Immunol       Date:  2005-11       Impact factor: 5.532

8.  Antiviral immune responses in mice deficient for both interleukin-2 and interleukin-4.

Authors:  M F Bachmann; H Schorle; R Kühn; W Müller; H Hengartner; R M Zinkernagel; I Horak
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

Authors:  Matthew A Williams; Aaron J Tyznik; Michael J Bevan
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

10.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.

Authors:  Ganesh A Kolumam; Sunil Thomas; Lucas J Thompson; Jonathan Sprent; Kaja Murali-Krishna
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

View more
  26 in total

1.  Predicting cytotoxic T-cell age from multivariate analysis of static and dynamic biomarkers.

Authors:  Catherine A Rivet; Abby S Hill; Hang Lu; Melissa L Kemp
Journal:  Mol Cell Proteomics       Date:  2010-12-30       Impact factor: 5.911

2.  Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients.

Authors:  S Uemoto; K Ozawa; T Kaido; A Mori; Y Fujimoto
Journal:  Clin Exp Immunol       Date:  2016-01-11       Impact factor: 4.330

3.  Late signals from CD27 prevent Fas-dependent apoptosis of primary CD8+ T cells.

Authors:  Douglas V Dolfi; Alina C Boesteanu; Constantinos Petrovas; Dong Xia; Eric A Butz; Peter D Katsikis
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

4.  Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation.

Authors:  Kazue Arimoto-Miyamoto; Norimitsu Kadowaki; Toshio Kitawaki; Satoshi Iwata; Chikao Morimoto; Takashi Uchiyama
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

5.  MHC class Ib-restricted CD8 T cells differ in dependence on CD4 T cell help and CD28 costimulation over the course of mouse polyomavirus infection.

Authors:  Amelia R Hofstetter; Mandy L Ford; Lucy C Sullivan; Jarad J Wilson; Annette Hadley; Andrew G Brooks; Aron E Lukacher
Journal:  J Immunol       Date:  2012-03-05       Impact factor: 5.422

Review 6.  Stimulating T Cells Against Cancer With Agonist Immunostimulatory Monoclonal Antibodies.

Authors:  Xue Han; Matthew D Vesely
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-20       Impact factor: 6.813

Review 7.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 8.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

9.  CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production.

Authors:  Victor Peperzak; Yanling Xiao; Elise A M Veraar; Jannie Borst
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

10.  CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets.

Authors:  Julie C Ribot; Ana deBarros; Dick John Pang; Joana F Neves; Victor Peperzak; Scott J Roberts; Michael Girardi; Jannie Borst; Adrian C Hayday; Daniel J Pennington; Bruno Silva-Santos
Journal:  Nat Immunol       Date:  2009-03-08       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.